A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Clinical trial NCT04404660 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04404660
- Sponsor
- Autolus Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2029-06-30
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.